At Freenome, we’re connecting people with
next-generation blood tests for early cancer detection powered by our multiomics platform.


Using a routine blood draw for
early cancer detection

Freenome's blood tests look beyond mutations to detect the body's own early-warning signs for cancer, incorporating a multidimensional view of both tumor- and immune-derived signatures that enable the early detection of cancer.

Decoding hidden patterns

By combining deep expertise in molecular biology and advanced computational techniques to recognize disease-associated patterns among billions of circulating, cell-free biomarkers, we are developing simple and accurate blood tests for early cancer detection and integrating the actionable insights into health systems to operationalize a feedback loop between care and science.


Pioneering a Multiomics Platform

Cancer Biology

Analyzing fragments of
DNA, RNA, proteins, and other
biomarkers circulating in
blood plasma.

Learn more

Artificial intelligence

Decoding the billions of
complex patterns associated
with the body's response to
specific tumor types.

Learn More

Detection & Treatment

Arming physicians with
powerful blood tests to find
cancer earlier and fight it
more effectively.

Learn More